Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Wesana Health Holdings Inc (WESA.CN)

Wesana Health Holdings Inc (WESA.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Help
Go To:
Fresh New Market Movers: Today’s Top Stock Picks for New & Trending Opportunities AccessWire - Wed Jun 15, 2022

Fresh New Market Movers: Today's Top Stock Picks for New & Trending Opportunities

ESTW.VN : 0.010 (unch)
CH.VN : 0.085 (unch)
ANZ.VN : 0.040 (unch)
TARSF : 0.1227 (+8.58%)
DELX.VN : 0.100 (+11.11%)
DPXCF : 0.0643 (-15.84%)
KNC.VN : 0.190 (-2.56%)
WDFCF : 0.1380 (+2.22%)
APLV.CN : 0.0300 (unch)
WESA.CN : 0.065 (unch)
Wesana Health CEO Daniel Carcillo to Keynote Charles River Symposium: Re-Imagining Substance Abuse, Addiction, and Mental Health Disorders with Psychedelic Therapies Globe Newswire - Wed Jun 8, 2022

His talk will kick-off the daylong biotechnology conference on cutting-edge therapies...

WESA.CN : 0.065 (unch)
WSNAF : 0.0209 (+2.96%)
Wesana Announces First Quarter 2022 Financial Results Globe Newswire - Tue May 31, 2022

CHICAGO and TORONTO, May 31, 2022 (GLOBE NEWSWIRE) -- Wesana Health Holdings Inc. (“Wesana” or the “Company”) (CSE: WESA; OTCQB: WSNAF), a data-driven...

WESA.CN : 0.065 (unch)
WSNAF : 0.0209 (+2.96%)
Wesana Health Outlines Accelerated Drug Development Pathway Globe Newswire - Tue May 10, 2022

CHICAGO and TORONTO, May 10, 2022 (GLOBE NEWSWIRE) -- Wesana Health Holdings Inc. (“Wesana” or the “Company”) (CSE: WESA; OTCQB: WSNAF), a data-driven...

WESA.CN : 0.065 (unch)
WSNAF : 0.0209 (+2.96%)
Wesana Announces Singular Focus on Drug Development Prompting a Strategic Review of its Clinics and Other Care Delivery Assets Globe Newswire - Thu May 5, 2022

CHICAGO and TORONTO, May 05, 2022 (GLOBE NEWSWIRE) -- Wesana Health Holdings Inc. (“Wesana” or the “Company”) (CSE: WESA; OTCQB: WSNAF), a data-driven...

WESA.CN : 0.065 (unch)
WSNAF : 0.0209 (+2.96%)
Wesana Health Reports Q4 2021 Financial Results and Provides Subsequent Period Highlights Globe Newswire - Mon May 2, 2022

CHICAGO and TORONTO, May 02, 2022 (GLOBE NEWSWIRE) -- Wesana Health Holdings Inc. (“Wesana” or the “Company”) (CSE: WESA; OTCQB: WSNAF), a data-driven...

WESA.CN : 0.065 (unch)
WSNAF : 0.0209 (+2.96%)
Wesana Is Exploring Broadening SANA-013 Lead Indication to Treat Major Depressive Disorder Globe Newswire - Mon Apr 18, 2022

Concurrently, the Company is launching a non-brokered private placement NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED...

WESA.CN : 0.065 (unch)
WSNAF : 0.0209 (+2.96%)
Wesana Health CEO Daniel Carcillo to Speak at Several Leading Investor and Industry Events Globe Newswire - Tue Mar 29, 2022

CHICAGO and TORONTO, March 29, 2022 (GLOBE NEWSWIRE) -- Wesana Health Holdings Inc. (“Wesana” or the “Company”) (CSE: WESA; OTCQB: WSNAF), a data-driven...

WESA.CN : 0.065 (unch)
WSNAF : 0.0209 (+2.96%)
Wesana Health Announces New Findings Indicating Psylocibin Potentiates Impact of an Anti-Depressant Globe Newswire - Tue Mar 22, 2022

CHICAGO and TORONTO, March 22, 2022 (GLOBE NEWSWIRE) -- Wesana Health Holdings Inc. (“Wesana” or the “Company”) (CSE: WESA; OTCQB: WSNAF), a data-driven...

WESA.CN : 0.065 (unch)
WSNAF : 0.0209 (+2.96%)
Wesana Health Announces Positive Feedback From Pre-IND Meeting With FDA on SANA-013 Globe Newswire - Mon Mar 14, 2022

Pre-IND Meeting is a Significant Milestone in the Clinical Development of SANA-013, Defining the Pathway to Initiate in-Human Clinical Trials in Q4 2022...

WESA.CN : 0.065 (unch)
WSNAF : 0.0209 (+2.96%)

Barchart Exclusives

Should You Buy This Beaten-Down AI Stock for Its 4% Dividend Yield? Barchart - Tue Apr 23, 6:30PM CDT
Sales of AI-enabled gadgets are expected to drive hardware sales over the next few years. PC maker HP looks like an AI play worth buying for its nearly 4% dividend yield and tepid valuations. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot